24 Jan 2025Open access
Decade-Long Trends in Hospitalization, Outcomes, and Emergency Department Visits for Inflammatory Bowel Diseases in the United States, 2010 to 2020Publisher siteCureus, Inflammatory Bowel Disease
UniversitiesMarvis Enyi
Active, last published 2026
In inflammatory bowel disease
Marvis
Enyi
Scholar“Research focused on Inflammatory Bowel Disease and adjacent fields.”
Imo State University
Claim Your Profile0
H-index
0
Citations
Marvis has not officially claimed their profile. If you are Marvis, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
arvis Enyi is a researcher working on Inflammatory Bowel Disease. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Marvis's work has been cited 0 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Inflammatory Bowel Disease×1Eosinophilic Esophagitis×1
04 · Where I am
Affiliations
Affiliation on published researchImo State UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works22 Sept 2024Open access
Cryptogenic Organizing Pneumonia Is Associated With Increased Mortality Risk in Hospitalizations for Systemic Lupus Erythematosus (SLE): A National Inpatient Sample AnalysisPublisher siteCureus, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Marvis?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you